Contraception

Keyphrases

Publications

2023

Allison L Gilbert, Danielle Gelfand, Jenifer Fortin, Danielle Roncari, Alisa B Goldberg
At-home urine pregnancy test assessment after mifepristone and misoprostol for undesired pregnancy of unknown location. Contraception (2023)
Paris Stowers, Ronald Heck, Katalin Csiszar, Bliss Kaneshiro
Just World Beliefs and Community-Level Abortion Stigma: An Exploratory Survey. Contraception (2023)
Jennifer Salcedo, Kelly Cleland, Deborah Bartz, Ivana Thompson
Society of Family Planning Clinical Recommendations: Emergency contraception. Contraception (2023)
Katherine Key, Alexandra Wollum, Charon Asetoyer, Maricela Cervantes, Alyssa Lindsey, Raquel Z Rivera, Janette Robinson Flint, Carmela Zuniga, Jessica Sanchez, Sarah E Baum
Challenges accessing contraceptive care and interest in over-the-counter oral contraceptive pill use among Black, Indigenous, and people of color: An online cross-sectional survey. Contraception (2023)
Kimberly K Scarsi, Laura M Smeaton, Anthony T Podany, Maxine Olefsky, Elizabeth Woolley, Elizabeth Barr, Michelle Pham, Sajeeda Mawlana, Khuanchai Supparatpinyo, Sivaporn Gatechompol, Emilia M Jalil, Luis Gadama, Sharlaa Badal-Faesen, Pablo F Belaunzaran-Zamudio, Catherine Godfrey, Susan E Cohn, Rosie Mngqibisa, null null
Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens. Contraception (2023)
Juliette Congy, Jean Bouyer, Elise de La Rochebrochard
Low-income women and use of prescribed contraceptives in a context of full health insurance coverage in France, 2019. Contraception (2023)
E A Mosley, A Monaco, N Zite, E Rosenfeld, J Schablik, N Rangnekar, M Hamm, S Borrero
U.S. physicians' perspectives on the complexities and challenges of permanent contraception provision. Contraception (2023)
Kavita Agarwal, Rupali Dewan
Evaluation of acceptability, safety and continuation rates of centchroman as post-abortion nonsteroidal contraceptive pill. Contraception (2023)
Gabriela A Aguilar, Lisbet S Lundsberg, Nancy L Stanwood, Aileen M Gariepy
Exploratory study of race- or ethnicity-based discrimination among patients receiving procedural abortion care. Contraception (2023)
Amir Sarayani, Almut Winterstein, Rodrigo Cristofoletti, Valva Vozmediano, Stephan Schmidt, Joshua Brown
Real-world effect of a potential drug-drug interaction between topiramate and oral contraceptives on unintended pregnancy outcomes. Contraception (2023)
Karen Borchert, Chelsea Thibodeau, Paige Varin, Heidi Wipf, Sarah Traxler, Christy M Boraas
Medication Abortion and Uterine Aspiration for Undesired Pregnancy of Unknown Location: A Retrospective Cohort Study. Contraception (2023)
Elizabeth G Raymond, Alice Mark, Daniel Grossman, Anitra Beasley, Kristyn Brandi, Jen Castle, Mitchell D Creinin, Caitlin Gerdts, Laura Gil, Melissa Grant, April Lockley, Jamila Perritt, Tara Shochet, Dominique Truan, Ushma D Upadhyay
Medication Abortion with Misoprostol-Only: A Sample Protocol. Contraception (2023)
Deirdre A Quinn, Florentina E Sileanu, Sonya Borrero, Lisa S Callegari
Reproductive health services: A missed opportunity in VA primary care? Contraception (2023)
Fran Bury, Vivian Iguyovwe, Mathew Trivett, Paula Baraitser
Patterns of use of emergency and oral contraceptives from an online service in the UK during the COVID-19 pandemic: a quantitative study of routinely collected data. Contraception (2023)
Jeffrey T Jensen, Isabel Reinecke, Teun M Post, Eeva Lukkari-Lax, Birte M Hofmann
Extended use of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg: A population pharmacokinetic approach to estimate in vivo levonorgestrel release rates and systemic exposure including comparison with two other LNG-IUSs. Contraception (2023)
Alexandra Wollum, Carmela Zuniga, Kelly Blanchard, Stephanie Teal
A commentary on progestin-only pills (POPs) and the "three-hour window" guidelines: Timing of ingestion and mechanisms of action. Contraception (2023)
Brandon L Crawford, Kristen N Jozkowski, Lucrecia Mena-Meléndez, Ronna C Turner
An exploratory examination of attitudes toward illegal abortion in the U.S. through endorsement of various punishments. Contraception (2023)
Kavita Agarwal, Rupali Dewan
Evaluation of acceptability, safety, and continuation rates of centchroman as postabortion nonsteroidal contraceptive pill. Contraception (2023)
Elizabeth A Mosley, Alexandra Monaco, Nikki Zite, Elian Rosenfeld, Jennifer Schablik, Niyati Rangnekar, Megan Hamm, Sonya Borrero
U.S. physicians' perspectives on the complexities and challenges of permanent contraception provision. Contraception (2023)
Annie Minns, Christine Dehlendorf, Alex F Peahl, Michele Heisler, Lauren E Owens, Barbara van Kainen, Kirsten Bonawitz, Michelle H Moniz
Elevating the Patient Voice in Contraceptive Care Quality Improvement: A Qualitative Study of Patient Preferences for Peripastum Contraceptive Care. Contraception (2023)
Allison L Gilbert, Danielle Gelfand, Jenifer Fortin, Danielle Roncari, Alisa B Goldberg
At-home urine pregnancy test assessment after mifepristone and misoprostol for undesired pregnancy of unknown location. Contraception (2023)
Madeline Thornton, Kavita Shah Arora
Reproductive Justice in Post-Roe America: Impact of Restricted Abortion Access on Patients Seeking Permanent Contraception. Contraception (2023)
Brandon L Crawford, Kristen N Jozkowski, Lucrecia Mena-Meléndez, Ronna C Turner
An Exploratory Examination of Attitudes Toward Illegal Abortion In the U.S. Through Endorsement of Various Punishments. Contraception (2023)
Gabriela A Aguilar, Lisbet S Lundsberg, Nancy L Stanwood, Aileen M Gariepy
Exploratory Study of Race- or Ethnicity-Based Discrimination Among Patients Receiving Procedural Abortion Care. Contraception (2023)
Katrina Kimport, Maryani Palupy Rasidjan
Exploring the emotional costs of abortion travel in the United States due to legal restriction. Contraception (2023)
Leah R Koenig, Elizabeth G Raymond, Marji Gold, Christy M Boraas, Bliss Kaneshiro, Beverly Winikoff, Leah Coplon, Ushma D Upadhyay
Mailing abortion pills does not delay care: a cohort study comparing mailed to in-person dispensing of abortion medications in the United States. Contraception (2023)
Annie Minns, Christine Dehlendorf, Alex F Peahl, Michele Heisler, Lauren E Owens, Barbara van Kainen, Kirsten Bonawitz, Michelle H Moniz
Elevating the patient voice in contraceptive care quality improvement: A qualitative study of patient preferences for peripastum contraceptive care. Contraception (2023)
Yan Che, Gui-Fang Hou, Hong-Ping Zhang, Heng Yang, Shu-Juan Lin, Tao Gan, Wei-Hua Yang, Chun-Hui Shi, Wei-Juan Ren, Ying-Qin Xu, Bao-Ming Yin, Ting-Ting Chen, Yu-Jie Gan, Yuan Zhang, Yan Zhang, Li-Nan Cheng
Effectiveness, safety, and acceptability of post-placental insertion of GyneFix postpartum intrauterine device among women undergoing cesarean section: A multicenter prospective cohort study in China. Contraception (2023)
Jennifer Salcedo, Kelly Cleland, Deborah Bartz, Ivana Thompson
Society of Family Planning Clinical Recommendation: Emergency contraception. Contraception (2023)
Lara Crystal-Ornelas, Shashi Sarnaik, Shokoufeh Dianat, Christine Dehlendorf, Kelsey Holt
Consent for Trainee Participation in Abortion Care: A Qualitative Study of Patient Experiences & Preferences in the United States. Contraception (2023)
Katrina Kimport, Maryani Palupy Rasidjan
Exploring the emotional costs of abortion travel in the United States due to legal restriction. Contraception (2023)
E A Mosley, A Monaco, N Zite, E Rosenfeld, J Schablik, N Rangnekar, M Hamm, S Borrero
U.S. physicians' perspectives on the complexities and challenges of permanent contraception provision. Contraception (2023)
Deirdre A Quinn, Florentina E Sileanu, Sonya Borrero, Lisa S Callegari
Reproductive health services: A missed opportunity in VA primary care? Contraception (2023)

volume 120, 2023

Jeffrey T Jensen, Isabel Reinecke, Teun M Post, Eeva Lukkari-Lax, Birte M Hofmann
Extended use of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg: A population pharmacokinetic approach to estimate in vivo levonorgestrel release rates and systemic exposure including comparison with two other LNG-IUSs. Contraception 120 (2023)
Katherine Key, Alexandra Wollum, Charon Asetoyer, Maricela Cervantes, Alyssa Lindsey, Raquel Z Rivera, Janette Robinson Flint, Carmela Zuniga, Jessica Sanchez, Sarah E Baum
Challenges accessing contraceptive care and interest in over-the-counter oral contraceptive pill use among Black, Indigenous, and people of color: An online cross-sectional survey. Contraception 120 (2023)
Gabriela A Aguilar, Lisbet S Lundsberg, Nancy L Stanwood, Aileen M Gariepy
Exploratory study of race- or ethnicity-based discrimination among patients receiving procedural abortion care. Contraception 120 (2023)
N W Shady, H A Farouk, H F Sallam
A randomized double blinded clinical trial to explore the clinical outcomes of vaginal isonicotinic acid hydrazide (INH) administration six hours prior to T380A intrauterine device insertion in persons delivered only by cesarean delivery. Contraception. 2022 Feb 18:9788. doi: 10.1016/j.contraception.2022.01.019. Epub ahead of print. Contraception 120 (2023)
N W Shady, H A Farouk, H F Sallam
A randomized double blinded clinical trial to explore the clinical outcomes of vaginal isonicotinic acid hydrazide (INH) administration six hours prior to T380A intrauterine device insertion in persons delivered only by cesarean delivery. Contraception. 2022 Feb 18:9788. doi: 10.1016/j.contraception.2022.01.019. Epub ahead of print. Contraception 120 (2023)
Gabriela A Aguilar, Lisbet S Lundsberg, Nancy L Stanwood, Aileen M Gariepy
Exploratory study of race- or ethnicity-based discrimination among patients receiving procedural abortion care. Contraception 120 (2023)
Katrina Kimport, Maryani Palupy Rasidjan
Exploring the emotional costs of abortion travel in the United States due to legal restriction. Contraception 120 (2023)
Gabriela A Aguilar, Lisbet S Lundsberg, Nancy L Stanwood, Aileen M Gariepy
Exploratory study of race- or ethnicity-based discrimination among patients receiving procedural abortion care. Contraception 120 (2023)
Allison L Gilbert, Danielle Gelfand, Jenifer Fortin, Danielle Roncari, Alisa B Goldberg
At-home urine pregnancy test assessment after mifepristone and misoprostol for undesired pregnancy of unknown location. Contraception 120 (2023)
Katrina Kimport, Maryani Palupy Rasidjan
Exploring the emotional costs of abortion travel in the United States due to legal restriction. Contraception 120 (2023)
Amir Sarayani, Almut Winterstein, Rodrigo Cristofoletti, Valva Vozmediano, Stephan Schmidt, Joshua Brown
Real-world effect of a potential drug-drug interaction between topiramate and oral contraceptives on unintended pregnancy outcomes. Contraception 120 (2023)
Amir Sarayani, Almut Winterstein, Rodrigo Cristofoletti, Valva Vozmediano, Stephan Schmidt, Joshua Brown
Real-world effect of a potential drug-drug interaction between topiramate and oral contraceptives on unintended pregnancy outcomes. Contraception 120 (2023)
Katherine Key, Alexandra Wollum, Charon Asetoyer, Maricela Cervantes, Alyssa Lindsey, Raquel Z Rivera, Janette Robinson Flint, Carmela Zuniga, Jessica Sanchez, Sarah E Baum
Challenges accessing contraceptive care and interest in over-the-counter oral contraceptive pill use among Black, Indigenous, and people of color: An online cross-sectional survey. Contraception 120 (2023)
Deirdre A Quinn, Florentina E Sileanu, Sonya Borrero, Lisa S Callegari
Reproductive health services: A missed opportunity in VA primary care? Contraception 120 (2023)
Deirdre A Quinn, Florentina E Sileanu, Sonya Borrero, Lisa S Callegari
Reproductive health services: A missed opportunity in VA primary care? Contraception 120 (2023)
Allison L Gilbert, Danielle Gelfand, Jenifer Fortin, Danielle Roncari, Alisa B Goldberg
At-home urine pregnancy test assessment after mifepristone and misoprostol for undesired pregnancy of unknown location. Contraception 120 (2023)
Jeffrey T Jensen, Isabel Reinecke, Teun M Post, Eeva Lukkari-Lax, Birte M Hofmann
Extended use of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg: A population pharmacokinetic approach to estimate in vivo levonorgestrel release rates and systemic exposure including comparison with two other LNG-IUSs. Contraception 120 (2023)